Dr Agarwals Health Care Ltd's Q4FY25 Quarter Results
- 29 May 2025
Result Summary
- Dr Agarwals Health Care Ltd reported a 16.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.
- Its expenses for the quarter were down by 21.8% QoQ and - - YoY.
- The net profit increased 46.3% QoQ and - - YoY.
- The earnings per share (EPS) of Dr Agarwals Health Care Ltd - at - during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 369.07 | 443.43 | 0.00 | -16.8% | - |
Total Expenses | 314.89 | 402.44 | 0.00 | -21.8% | - |
Profit Before Tax | 54.18 | 40.99 | - | 32.2% | NaN% |
Tax | 12.85 | 12.75 | 0.00 | 0.8% | - |
Profit After Tax | 41.32 | 28.24 | 0.00 | 46.3% | - |
Earnings Per Share | 0.00 | 0.70 | 0.00 | -100.0% | - |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Dr Agarwals Health Care Ltd is a prominent player in the healthcare sector, primarily known for providing ophthalmology services. The company operates a network of eye hospitals offering a range of services including cataract surgeries, LASIK, and advanced retinal treatments. While specific recent developments are not provided, as of the last known data, the company has been expanding its presence in India and internationally. The focus remains on delivering high-quality eye care services, supported by advanced medical technology and a team of specialized doctors. Without recent updates, further details on the company are not available.
Revenue
In Q4 FY25, Dr Agarwals Health Care Ltd reported a total income of ₹369.07 crores, showing a decline from the previous quarter (Q3 FY25), where the total income was ₹443.43 crores. This represents a quarter-over-quarter (QoQ) decrease of 16.8%. Comparisons to the same quarter in the previous fiscal year (Q4 FY24) are not possible due to the absence of data. The reduction in revenue from the last quarter may indicate changes in operational performance or market dynamics affecting the quarterly results.
Profitability
During Q4 FY25, the company reported a profit before tax of ₹54.18 crores, which increased from Q3 FY25's profit before tax of ₹40.99 crores. This reflects a QoQ growth of 32.2%. The tax expense for Q4 FY25 was ₹12.85 crores, slightly higher than the ₹12.75 crores in Q3 FY25, marking a 0.8% increase. Consequently, the profit after tax for Q4 FY25 stood at ₹41.32 crores, up from ₹28.24 crores in the previous quarter, resulting in a significant QoQ increase of 46.3%. Earnings per share in Q4 FY25 were recorded as zero, contrasting sharply with Q3 FY25, where it was ₹0.70, indicating a 100% decline.
Operating Metrics
Total expenses for Q4 FY25 were ₹314.89 crores, which showed a decrease from the ₹402.44 crores recorded in Q3 FY25. This represents a QoQ reduction of 21.8%, indicating a significant decrease in operational expenditures. The data does not provide information on specific operating metrics or ratios such as P/E ratio, debt-to-equity ratio, or current ratio, limiting further analysis in this section. However, the notable reduction in total expenses versus income resulted in improved profitability for the quarter. The absence of year-over-year (YoY) data restricts further analysis regarding long-term trends in operating efficiency.